A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report.
Cecilia VecoliIlenia FoffaSimona VittoriniNicoletta BottoAugusto EspositoSabrina CostaValeria PiagneriPierluigi FestaLamia Ait-AliPublished in: Personalized medicine (2024)
We report the clinical presentation and genetic screening of a 31-year-old man with dilatation of the aortic root and ascending aorta and a positive family history for aortic dissection and sudden death. A novel heterozygous variant in a splice acceptor site (c.1600-1G>T) of TGFβR2 gene was identified by using a targeted multi-gene panel analysis. Bioinformatics tools predicted that the c.1600-1G>T variant is pathogenic by altering acceptor splice site at - 1 position affecting pre-mRNA splicing. These data confirm that the diverging splicing in the TGF-β pathway genes may be an important process in aneurismal disease and emphasize the utility of genetic sequencing in the identification of high-risk patients for a more patient's management able to improve outcomes and minimize costs for the care of patients with heritable thoracic aortic aneurysm and dissection.
Keyphrases
- aortic dissection
- aortic aneurysm
- genome wide
- copy number
- transforming growth factor
- genome wide identification
- end stage renal disease
- case report
- dna methylation
- newly diagnosed
- healthcare
- chronic kidney disease
- type diabetes
- early onset
- spinal cord
- peritoneal dialysis
- single cell
- electronic health record
- pain management
- transcription factor
- binding protein
- adipose tissue
- patient reported outcomes
- big data
- aortic valve
- spinal cord injury
- atrial fibrillation
- artificial intelligence